Page 3
-
FDA approves generic Truvada — but there’s a catch
The move took advocates by surprise, since it wasn’t expected until 2021. However, the announcement has led to confusion about how soon it might be available.
-
Good news: HIV infection rate has fallen dramatically in U.S.
New calculations to better track HIV infections confirm that the U.S. is seeing a strong and steady decline.
-
Bill & Melinda Gates Foundation gives $140 million to develop PrEP pump
A device to deliver a daily dose of an HIV prevention drug could be a huge leap forward in the fight against HIV/AIDS.
-
First human trials of long-acting injectable drug to prevent HIV underway
The hope is that this drug, injected once every 8 weeks, can safely protect men and transgender women from HIV infection
-
How can we use HIV prevention techniques to lower smoking rates?
Our community has twice as many deaths from cigarettes than HIV every year. New advances can help us lower both rates by 95% or more.
-
Miami leads America’s top ten cities with highest rates of HIV
Despite new treatment methods, Human Immunodeficiency Virus remains one of the most common and most dangerous STDs in the U.S.
-
Despite second case of HIV, PrEP still ‘most effective tool for HIV prevention’
A second man taking PrEP for HIV prevention has tested positive. Let’s take a deeper dive beyond the story to see what it means for gay men taking Truvada.
-
Mike Pence’s top seven most homophobic moments (out of many)
Indiana Governor Mike Pence is a darling of the religious right, and with good reason.
-
Revealing data shows huge racial divide in HIV prevention meds usage
Whites make up 27% of new U.S. HIV cases but 75% of current PrEP consumers.